Abstract

Bisphosphonates have long been essential in managing various bone-related disorders like osteoporosis and metastatic bone disease. However, recent advancements have led to the emergence of novel bisphosphonate agents and innovative treatment strategies, reshaping the therapeutic landscape. This article provides an overview of the latest developments in bisphosphonate therapy, highlighting novel agents, targeted delivery systems, combination therapies, and personalized approaches. By exploring these advancements, this article aims to offer insights into the evolving landscape of bisphosphonate therapy and its potential impact on bone health management